Playback speed
10 seconds
2021 ASCO Highlights on Mutation/Fusion Directed Therapies for Thyroid Cancer: BRAF V600E, NTRK, RET, ALK
By
Annual Midwest Regional ASCO Review 2021
FEATURING
Maria Cabanillas
By
Annual Midwest Regional ASCO Review 2021
FEATURING
Maria Cabanillas
24 views
July 15, 2021
Login to view comments.
Click here to Login